CMS unveils payment model to boost GLP-1 access for Medicare Part D, Medicaid
Source: SeekingAlpha
2025-12-29 13:17:16 ET
More on Novo Nordisk, Eli Lilly
- Novo Nordisk: The Real Comeback Starts Now With The Wegovy Pill
- Eli Lilly: Mr. Market Finally Woke Up, But I'm Not Out Yet (Rating Downgrade)
- Eli Lilly: Short-Term Upside Exhausted (Rating Downgrade)
- GLP-1 weight loss meds lead to changes in consumer food demand - study
- Medicare pilot programs aim to reduce prescription drug spend
Read the full article on Seeking Alpha
For further details see:
CMS unveils payment model to boost GLP-1 access for Medicare Part D, Medicaid
Elevance Health Inc.
NASDAQ: ELV
ELV Trading
0.27% G/L:
$395.6099 Last:
170,875 Volume:
$394.27 Open:
ELV Latest News
May 04, 2026 02:10:00 pm
Elevance Health Advances Efforts to Close Critical Gaps in Mental Health CareMay 01, 2026 08:00:00 am
Elevance Health Names Best in Class Primary Care Practices in Care Provider Recognition ProgramApril 30, 2026 08:00:00 am
Elevance Health's Affiliated Health Plans Deliver More Predictable, Lower Healthcare Costs for Small BusinessesApril 29, 2026 05:51:34 pm
Inside Elevance Health's push to keep humans at the center of AI-driven careELV Stock Data
$71,870,267,762
220,108,764
N/A
827
N/A
Medical Service Plans
Healthcare
US
Indianapolis
